Illinois Compiled Statutes - Full Text

  1. Home
  2. Legislation
  3. Illinois Compiled Statutes

Illinois Compiled Statutes - Full Text

Illinois Compiled Statutes (ILCS)

Updating the database of the Illinois Compiled Statutes (ILCS) is an ongoing process. Recent laws may not yet be included in the ILCS database, but they are found on this site as Public Acts soon after they become law. For information concerning the relationship between statutes and Public Acts, refer to the Guide.

Because the statute database is maintained primarily for legislative drafting purposes, statutory changes are sometimes included in the statute database before they take effect. If the source note at the end of a Section of the statutes includes a Public Act that has not yet taken effect, the version of the law that is currently in effect may have already been removed from the database and you should refer to that Public Act to see the changes made to the current law.


305 ILCS 5/5-5.24a

    (305 ILCS 5/5-5.24a)
    Sec. 5-5.24a. Remote ultrasounds and remote fetal nonstress tests; reimbursement.
    (a) Subject to federal approval, for dates of service beginning on and after January 1, 2025, the Department shall reimburse for remote ultrasound procedures and remote fetal nonstress tests when the patient is in a residence or other off-site location from the patient's provider and the same standard of care is met as would be present during an in-person visit.
    (b) Remote ultrasounds and remote fetal nonstress tests are only eligible for reimbursement when the provider uses digital technology:
        (1) to collect medical and other forms of health data
    
from a patient and to electronically transmit that information securely to a health care provider in a different location for interpretation and recommendation;
        (2) that is compliant with the federal Health
    
Insurance Portability and Accountability Act of 1996; and
        (3) that is approved by the U.S. Food and Drug
    
Administration.
    (c) A fetal nonstress test is only eligible for reimbursement with a place of service modifier for at-home monitoring with remote monitoring solutions that are cleared by the U.S. Food and Drug Administration for on-label use for monitoring fetal heart rate, maternal heart rate, and uterine activity.
    (d) The Department shall issue guidance to implement the provisions of this Section.
(Source: P.A. 103-593, eff. 6-7-24; 104-417, eff. 8-15-25.)